Merck Serono resubmits oral MS therapy to FDA

June 8, 2010
Research and Development Cladribine, MS, Merck KGaA

Merck Serono has re-submitted its oral multiple sclerosis therapy cladribine to US regulators. Merck Serono, a Swiss division of Merck …

Sanofi to develop monoclonal antibody jabs

June 8, 2010
Research and Development Sanofi Pasteur, Vivalis, vaccines

Sanofi-Aventis is to develop a range of monoclonal antibody for use against infectious diseases. The French pharma company’s vaccines arm …

EU regulators to assess potential lupus breakthrough drug

June 8, 2010
Sales and Marketing Benlysta, Human Genome Sciences, Lupus

GlaxoSmithKline and Human Genome Sciences have submitted a marketing application to the European Medicines Agency for their new lupus drug. …

CME Spotlight: Power to the people

June 8, 2010
Medical Communications, Sales and Marketing CME Spotlight, transparency

The UK general election is now over and as we stayed up to watch the count, or woke on the …

EMA under fire for blocking data access

June 8, 2010
Research and Development, Sales and Marketing Acomplia, Alli, EMA, Xenical, data

The European ombudsman has called for the European Medicines Agency to grant access to clinical study reports and trial protocols …

Novo ethics tools

Digital Pharma: Novo Nordisk’s online ethics tools

June 8, 2010
Medical Communications, Sales and Marketing Novo Nordisk, compliance, ethics

Two new e-learning tools have been launched to help shed some light on ethical grey areas and give individuals a …

Idis appoints Richard Greatorex

June 8, 2010
Research and Development, Sales and Marketing IDIS, appointment, research and development, sales and marketing

Richard Greatorex has joined specialist medicines supplies company Idis as international marketing manager for its global headquarters in the UK. …

Manufacturing news in brief

June 8, 2010
Manufacturing and Production AHP Manufacturing, Caraco Pharmaceutical, Hospira, KV Pharmaceutical, Pharmalucence

The pharmaceutical manufacturing sector had another week of mixed fortunes, with yet more recalls being announced and a former Wyeth …

Chiltern Achieves Supplementary Accreditation from the Medicines & Healthcare Products Regulatory Agency

June 7, 2010
Research and Development

Dr Brian Sanderson, Medical Director, Chiltern Early Phase, explains, “In November 2007, the MHRA launched a voluntary accreditation scheme for …

Pfizer launches UK pharmacy service

June 7, 2010
NHS, NHS Constitution, NHS Health Check, Pfizer

Pfizer has launched a new pharmacy-based service that will enable Primary Care Trusts in England to provide the NHS Health …

Nexium

AZ submits Nexium-aspirin combination for EU approval

June 7, 2010
Sales and Marketing AstraZeneca, Nexium, aspirin

AstraZeneca is seeking European approval for a new version of its anti-ulcer blockbuster Nexium that combines the pill with aspirin. …

Avastin packs

Avastin promising in ovarian cancer

June 7, 2010
Research and Development ASCO, avastin

Roche’s Avastin took a step closer to winning an additional indication after phase III trial data showed the blockbuster cancer …

Pfizer recalls Indian-made intravenous drugs

June 7, 2010
Manufacturing and Production Claris Lifesciences, Pfizer, manufacturing compliance, recalls

Pfizer is recalling two intravenous antibiotics and an anti-nausea medication after particulate matter was found to be floating in them, leading …

Teva will invest $56m in Canadian plant

June 7, 2010
Manufacturing and Production Canada, Teva, production

Israeli generic drugmaker Teva Pharmaceutical Industries is planning to spend $54 million to expand a Canadian production plant for solid …

Careers Voice: Online recruitment? Don’t take it at face value

June 7, 2010
Business Services careers voice, rsa

With social networking and online sites offering low cost solutions, are the days of traditional recruitment firms numbered? Without face-to-face …

UCB’s Kola joins Astex board

June 5, 2010
Research and Development Astex, UCB, appointment, research and development

Dr Ismail Kola has joined the board of directors at UK biotech company Astex Therapeutics. Astex’s non-executive chairman Peter Fellner …

Sanofi signs deal on pre-clinical cancer drugs

June 4, 2010
Research and Development Cancer, Sanofi

Sanofi-Aventis has signed a deal with US biotech company Ascenta to co-develop new oncology treatments aimed at restoring ‘apoptosis’ or …

ASCObag

ASCO cancer conference opens

June 4, 2010
Research and Development ASCO, Cancer, lenalidomide, rituximab

One of the most important dates in the pharmaceutical industry’s calendar, the ASCO cancer conference begins today. The American Society …

Vaccine for brain cancer shows promise

June 3, 2010
Research and Development Cancer, GBM, ImmunoCellular

Early stage trials of a new treatment for the brain cancer glioblastoma multiforme have shown promise. ICT-107 is being developed …

NICE rejects Xolair for children

June 3, 2010
Sales and Marketing NICE, Xolair, asthma

The drug was first approved in Europe in November 2005 for patients aged 12 or older, and gained NICE approval …

The Gateway to Local Adoption Series

Latest content